Open-label Clinical Trial to Evaluate the Efficacy of Sodium Oxybate (Xyrem) in the Treatment of Two Under-recognized Clinical Conditions: Post-traumatic Narcolepsy and Post-traumatic Hypersomnia
Phase of Trial: Phase 0
Latest Information Update: 21 Aug 2019
Price : $35 *
At a glance
- Drugs Sodium oxybate (Primary)
- Indications Hypersomnia; Narcolepsy
- Focus Therapeutic Use
- 16 Aug 2019 Planned initiation date(estimated date for recruitment of first subject) changed from 1 Mar 2019 to 1 Sep 2019.
- 07 Feb 2019 Planned initiation date changed from 1 Oct 2018 to 1 Mar 2019.
- 12 Nov 2018 Status changed from not yet recruiting to recruiting.